Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Urinary Biomarkers in Pediatric Overactive Bladder
NCT02704013Unknown
- Sponsor
- Children's Hospital Zagreb
- Start
- Apr 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of oxybutynin in overactive bladder (OAB), sponsored by Children's Hospital Zagreb. Primary endpoint: Initial success at 6 months. Status: unknown.
02
Drugs
oxybutynin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT02704013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02704013.